2023-08-23 17:48:17 ET
More on CVS Health
- CVS Health: Blue Shield Runs To Amazon, But Valuation Still Makes Sense
- Walgreens Vs. CVS: I Call A Tie Now Based On A Peter Lynch Evaluation
- CVS: In Search Of A Major Low
- CVS Health: Second Quarter Was Only Decent, But Integration Is On Track
- CVS in slight recovery after PBM contract loss
- CVS Health says no near-term impact from PBM contract loss
- Cigna down 7% as casualty of CVS/Blue Shield PBM decision
- CVS Health to lose PBM deal with Blue Shield of California - WSJ
- Seeking Alpha’s Quant Rating on CVS Health
- Earnings data for CVS Health
- Dividend scorecard for CVS Health
For further details see:
CVS Health launches biosimilars business, with Humira rival as first product